Evidence map›Paper›PMID 35624809›Full record

ArticleAntioxidants (Basel, Switzerland)2022

Identification of a Novel Class of Anti-Melanogenic Compounds, (

Yeongmu Jeong, Sojeong Hong, Hee Jin Jung, Sultan Ullah, YeJi Hwang, Heejeong Choi, Jeongin Ko, Jieun Lee, Pusoon Chun, Hae Young Chung and 1 more

Open access · goldAbstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.4field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Anti-Browning Effect of 2-Mercaptobenzo[Antioxidants (Basel, Switzerland) · 2023
    Article
  4. Heterocyclic Compounds as Synthetic Tyrosinase Inhibitors: Recent Advances.International journal of molecular sciences · 2023
    Review
  5. Article
  6. Design and Synthesis of (Molecules (Basel, Switzerland) · 2023
    Article
  7. Article
  8. Design and Synthesis of (Antioxidants (Basel, Switzerland) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Yeongmu JeongLaboratory of Medicinal Chemistry, Department of Manufacturing Pharmacy, College of Pharmacy, Pusan National University, Busan 46241, Korea.
Sojeong HongLaboratory of Medicinal Chemistry, Department of Manufacturing Pharmacy, College of Pharmacy, Pusan National University, Busan 46241, Korea.
Hee Jin JungDepartment of Pharmacy, College of Pharmacy, Pusan National University, Busan 46241, Korea.ORCID 0000-0001-7212-5572
Sultan UllahDepartment of Molecular Medicine, The Scripps Research Institute, Jupiter, FL 33458, USA.
YeJi HwangLaboratory of Medicinal Chemistry, Department of Manufacturing Pharmacy, College of Pharmacy, Pusan National University, Busan 46241, Korea.
Heejeong ChoiLaboratory of Medicinal Chemistry, Department of Manufacturing Pharmacy, College of Pharmacy, Pusan National University, Busan 46241, Korea.
Jeongin KoLaboratory of Medicinal Chemistry, Department of Manufacturing Pharmacy, College of Pharmacy, Pusan National University, Busan 46241, Korea.
Jieun LeeLaboratory of Medicinal Chemistry, Department of Manufacturing Pharmacy, College of Pharmacy, Pusan National University, Busan 46241, Korea.
Pusoon ChunCollege of Pharmacy and Inje Institute of Pharmaceutical Sciences and Research, Inje University, Gimhae 50834, Korea.
Hae Young ChungDepartment of Pharmacy, College of Pharmacy, Pusan National University, Busan 46241, Korea.ORCID 0000-0002-3215-8828
Hyung Ryong MoonLaboratory of Medicinal Chemistry, Department of Manufacturing Pharmacy, College of Pharmacy, Pusan National University, Busan 46241, Korea.ORCID 0000-0003-1119-7112
Pusan National University · KRInje University · KRScripps Research Institute · US

Funding

National Research Foundation of Korea NRF-2021R1I1A1A01052284; NRF-2020R1A2C1004198
6 · The paper itself

Abstract

The rate-determining role of tyrosinase makes it a critical component in the mechanism that is responsible for melanogenesis. Thirteen (

Indexed as

anti-melanogenesisdocking simulationdual mechanismkojic acidradical scavengingROStyrosinase

Identifiers

PMID35624809
PMCPMC9137581
OpenAlexW4280552919

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.